Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Collection and Storage of Umbilical Cord Blood for Transplantation

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: November 9, 2012
Last updated: August 16, 2016
Last verified: August 2016

The goal of this study is to collect blood samples from the umbilical cords of newborn babies, as soon as they are delivered, and to place these samples in the MD Anderson Cord Blood Bank. Your sample may be included in the National Cord Blood Inventory (NCBI) which is part of the CW Bill Young Cell Transplantation Program. The NCBI is a federally-supported program to assist in the collection of cord blood. Cord blood will be made available to patients through The National Marrow Donor Program (NMDP). These samples may then be offered to MD Anderson and other institutions for patients who need a bone marrow transplant and do not have a donor. The MD Anderson Cord Blood Bank will have the rights to release cord blood units to these institutions around the world according to established bone marrow transplant donor criteria, for a fee to cover costs.

Cord blood samples that are collected and then do not meet the clinical requirements for patient use may also be used at MD Anderson or other institutions either for research or for quality purposes to improve cord blood banking procedures. If not suitable for patient use or for research purposes, the cord blood unit may be thrown away.

Cord Blood Stem Cell Transplantation
Cord Blood Transplantation
Hematopoietic Stem Cell Transplantation

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Collection and Storage of Umbilical Cord Blood for Transplantation

Further study details as provided by M.D. Anderson Cancer Center:

Primary Outcome Measures:
  • Public Cord Blood Banking [ Time Frame: 10 years ]
    Collection and storage of umbilical cord blood units from normal donors for banking and ultimate transplantation into patients.

Biospecimen Retention:   Samples With DNA
Blood samples from the umbilical cords of newborn babies, a minimum of 40 ml is needed for processing.

Estimated Enrollment: 250000
Study Start Date: April 2005
Estimated Primary Completion Date: June 2099 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Neonates delievered by women age 18 years or older.

Inclusion Criteria

  1. Pregnant women age 18 or older. Cord blood will not be collected from a minor.
  2. Able to give verbal informed consent prior to collection of the cord blood.
  3. Able to give written informed consent prior to collection of the cord blood.
  4. Willing to provide a personal and family medical history (if available) of herself and the biologic father (if available), prior to or following collection of the cord blood.
  5. Willing to consent to testing of her blood and the cord blood for infectious diseases, including human immunodeficiency virus (HIV), human T cell lymphotrophic virus (HTLV), hepatitis B and C, cytomegalovirus (CMV), syphilis (RPR), Trypanosoma cruzi (Chagas) and West Nile Virus (WNV). Incomplete tests or positive infectious disease testing results may result in the cord blood unit being deemed unacceptable for clinical use.
  6. Willing to consent to testing the cord blood for HLA type, ABO/RhD type, newborn screening and microbial cultures.

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01728545

Contact: Elizabeth Shpall, MD 713-745-2161

United States, Texas
MD Anderson Cord Blood Bank Collection Sites Recruiting
Houston, Texas, United States, 77030
Principal Investigator: Elizabeth Shpall, MD         
Sponsors and Collaborators
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Study Chair: Elizabeth Shpall, MD M.D. Anderson Cancer Center
  More Information

Additional Information:
Responsible Party: M.D. Anderson Cancer Center Identifier: NCT01728545     History of Changes
Other Study ID Numbers: LAB04-0249
R01CA061508 ( US NIH Grant/Contract Award Number )
Study First Received: November 9, 2012
Last Updated: August 16, 2016

Keywords provided by M.D. Anderson Cancer Center:
Cord blood registry
Umbilical Cord Blood
fetal blood
Placental Blood Stem Cell Transplantation
cord blood unit total nucleated cell
hematopoietic progenitor cells
Hematopoietic Stem Cell Transplantation
CD34-positive(+) cell
human leukocyte antigen
allogeneic transplantation processed this record on May 25, 2017